cerebral stroke. G46.4
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Acute ischemic stroke in the MCA arterial territory NIHSS score =6 and <13 Absence of Large Vessel Occlusion (LVO) Thrombectomy not performed No improvement in symptoms related to the patient's recent acute stroke following relevant treatments except thrombectomy Absence of hemorrhage, either initially or following acute phase treatments
Exclusion criteria
Exclusion criteria: Known coagulation disorder or platelet dysfunction (but consumers of platelet inhibitors are allowed) Presence of Hemorrhage or Hemorrhagic Transformation at baseline or following treatment Hematological causes of stroke resulting from cell stasis. Liver failure Renal dysfunction with GFR below 30 Pregnant or breastfeeding patients Justifiable metabolic causes for Stroke-like symptoms Patients with evidence of life-threatening infections or life-threatening illness Presence of known cancer in the patient Positive HIV, HBV, HCV test Inability to tolerate MRI imaging required before the procedure
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary and secondary outcomes: To evaluate the safety of the bleeding event, paraplegia, blindness, coma, decreased level of consciousness, and death are measured during and up to one year after the intervention. Timepoint: Measurements are taken at 3, 6 month, and 1 year intervals after the intervention. Method of measurement: To evaluate the effectiveness of infarct size, the NIHH, mRS, and Barthel indices. | — |
Countries
Iran (Islamic Republic of)
Contacts
Tehran University of Medical Sciences